Symbol="SRPT"
AssetType="Common Stock"
Name="Sarepta Therapeutics Inc"
Description="Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="873303"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="9699575000"
EBITDA="-539008000"
PERatio="None"
PEGRatio="159.25"
BookValue="7.65"
DividendPerShare="0"
DividendYield="0"
EPS="-12.66"
RevenuePerShareTTM="11.11"
ProfitMargin="-1.143"
OperatingMarginTTM="-0.596"
ReturnOnAssetsTTM="-0.119"
ReturnOnEquityTTM="-1.421"
RevenueTTM="975683000"
GrossProfitTTM="-78066000"
DilutedEPSTTM="-12.66"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.202"
AnalystTargetPrice="175.37"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.49"
PriceToBookRatio="25.74"
EVToRevenue="12.09"
EVToEBITDA="-17.47"
Beta="0.99"
num_52WeekHigh="159.89"
num_52WeekLow="89.75"
num_50DayMovingAverage="122.32"
num_200DayMovingAverage="123.62"
SharesOutstanding="93149000"
DividendDate="None"
ExDividendDate="None"
symbol="SRPT"
open="103.74"
high="105.48"
low="102.69"
price="104.13"
volume="665826.00"
latest_trading_day="2023-07-26"
previous_close="104.26"
change="-0.13"
change_percent="-0.1247%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="29"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="1491103"
Change_recent_avg="-0.28"
Delta_recent_avg="4.39"
Variance_recent_avg="2.2"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="1139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_negative_thumbnail_id_2="1102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_neutral_thumbnail_id_1="559"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="606"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0102.jpeg"
image_positive_thumbnail_id_2="995"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0157.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
